This week in healthcare 3D printing and 3D technologies: the FDA cleared the first 3D-printed implant made at a point-of-care institution, as Walter Reed’s 3D Medical Applications Center and 3D Systems turned a hospital into a cleared device manufacturer. Plus peer-reviewed bioprinting advances in vascularized bone and a breast-cancer tumor model, a patient-specific PEKK chest-wall reconstruction, catheter and pharmaceutical 3D printing of personalized peptides, and the latest on New Approach Methodologies (NAMs) and dental 3D printing from The Lattice podcast.
The big thing
The hospital becomes the manufacturer
On July 28, 3D Systems announced that Walter Reed National Military Medical Center’s 3D Medical Applications Center (3D MAC), working with the Defense Health Agency, had won FDA premarket clearance for its Titanium Cranial Plate (TCP) System. The implants would be used to treat U.S. active-duty personnel and fighters suffering from traumatic head injuries worldwide. This would be the first FDA-cleared implant ever granted to a point-of-care institution. This is also the first time a hospital crossing the line from care provider to cleared device manufacturer, inside its own walls.
That line has been blurry for years. The FDA regulates the manufacturing process and its output, not the printer; its 2021 discussion paper sketched models for producing devices at the point of care but left the framework famously unsettled. A cleared implant from a hospital-run lab would be the first hard data point on what “compliant” looks like in practice.
The commercial signal is there. Point-of-care is becoming a business. The same week, 3DPrint.com reported Ricoh selling its FDA-cleared, point-of-care patient-specific device unit to a management buyer who rebranded it Myrava (stay tuned for our upcoming podcast with Myrava soon). This serves as evidence that the segment is worth owning as a standalone company. In Europe, a Madrid public hospital became a certified device manufacturer under EU rules. What’s more interesting is the fact that vendors like 3D Systems that can carry a hospital from concept to clearance are also selling regulatory capability as much as printers.
Clinically, the case for in-house patient-specific implants is maturing. According to PubMed, a 2026 University of Basel study with 3D Systems showed point-of-care printing of functionalized PEEK cranio-maxillofacial implants within clinically acceptable accuracy. The promise is faster, better-fitting reconstructions for the patient in front of you.
Overall, this is an encouraging piece of news to all in medical 3D printing. However, whether it opens the floodgates or stays a well-resourced military exception is the question worth watching.
Regulatory watch
- First FDA-cleared implant from a point-of-care institution (Walter Reed 3D MAC Titanium Cranial Plate System) — 3D Systems-enabled 510(k) cleared Jul 28; the week’s one additive-manufactured clearance (and the subject of The big thing). No other new AM 510(k)s surfaced; DARPA and ARPA-H were quiet.
Clinical & research
- miRNA-programmed spheroids bioprint vascularized bone (Chemical Engineering Journal · via PubMed) — Penn State / Johns Hopkins report ~91% closure of critical-size skull defects in mice with vessel-like structures – a step toward vascularized bone grafts.
- 3D-bioprinted breast cancer-stroma model maps invasion (Advanced Healthcare Materials · via PubMed) — A Wurzburg team shows adipose-derived stromal cells drive tumor-cell migration – a more human-relevant model for cancer drug testing.
- Israel’s first full 3D-printed chest-cage reconstruction (VoxelMatters) — Clalit-Beilinson surgeons rebuilt a sarcoma patient’s sternum and ribs with a custom PEKK implant – patient-specific implants moving from novelty toward routine.
Also this week
- Bioprinted diaphragmatic-hernia patch (proof of concept) — France; myoblasts and fibroblasts bioprinted on a biodegradable albumin membrane, shielded by PLGA microscaffolds (Biofabrication, via PubMed).
- UNO wins $8M NSF award to launch the NE3D center — A statewide Nebraska hub for 3D-printed prosthetics and assistive devices, antimicrobial materials, and patient-specific solutions.
- TE Connectivity automates catheter-shaft jacketing — A new process 3D-prints jacketing directly onto catheter shafts (Galway), replacing a manual assembly step.
- ‘Little Wheels, Big Dreams’: a maker prints mobility trainers — MD+DI profiles Anthony Duran, who prints kid-friendly mobility trainers (~$265 in parts) and donates them where insurance won’t.
- PharmaTher tests GMP peptide 3D printing — With Craft Health’s room-temperature CraftMake platform, aimed at 503A compounding pharmacies for personalized peptide doses.
- KIST prints texture-tuned food for dysphagia — A chlorella-and-starch food ink prints meals matched to a patient’s swallowing ability – 3D printing reaches clinical nutrition.
- A primer on food-grade 3D printing — Useful reference on why printed parts aren’t automatically food-safe – and how food-grade differs from biocompatible.
- Phase3D supports NASA metal-AM flight qualification — Off our usual beat, but the in-situ, ‘born-qualified’ QA idea echoes into how regulated medical AM proves quality.
From 3DHEALS
- Episode 122: New Approach Methodologies (NAMs) with Dr. Lowry Curley — Brain organoids and organ-on-a-chip vs. animal testing – and why the FDA’s 2025-26 guidance is shifting pharma’s posture.
- Webinar (Aug 20): New Approach Methodologies – From Theory to Validation — Andrew Lee (FluidForm Bio) and Graham Craig (VoxCell) on validating NAMs with biofabrication and microfluidics. Register to join.
- Episode 119: Where Is Dental 3D Printing? with Dr. Nabeel Cajee — 3DHEALS’ dental ambassador on digital workflows, same-day restorations, and the printed-ceramics-vs-zirconia materials gap.
Comments